NEO
Ticker
NeoGenomics, Inc.
NEO · Healthcare · NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United KingdomNeoGenomics, Inc. (NEO), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 3 corporate insiders: 1 purchase and 3 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 7 and filed Sep 10. The most active filer was Gilbert Cisneros with 2 filings.
Add to watchlistFilings, ttm
4
1 buy · 3 sells
Traders, ttm
4
1 congress · 3 insiders
Volume, ttmiDollar value disclosed in the window
$857K
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 7
Filed Sep 10
ADViAverage daily dollar volume
$44.0M
market data
Share price · 12M
$19.89 (+136.8%)
Adjusted for splits and dividends.
Volume by month
Buys $427K
Sells $849K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
GCRecent filings
Gilbert CisnerosPURCHASE
Representative
$8K$1K–15K bracket
Exec Aug 7
Filed Sep 10 Greg D AunanSALE Chief Accounting Officer $321K
20,000 sh × $16.07
Exec Aug 4
Filed Aug 6 · 4:02 PM ET Warren StoneSALE Pres & Chief Operating Officer $277K
22,128 sh × $12.50
Exec Jan 20
Filed Jan 21 · 5:30 PM ET Alicia C OlivoSALE EVP, GC & Business Development $251K
20,916 sh × $12.00
Exec Nov 25 2025
Filed Nov 28 2025 · 5:30 PM ET Jeffrey Scott ShermanPURCHASE Chief Financial Officer $112K
20,000 sh × $5.62
Exec Aug 6 2025
Filed Aug 6 2025 · 4:07 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec May 7 2025
Filed Jun 6 2025 Anthony P. ZookPURCHASE Chief Executive Officer $149K
18,900 sh × $7.88
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET Jeffrey Scott ShermanPURCHASE Chief Financial Officer $150K
20,000 sh × $7.51
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET